These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25341088)

  • 1. Limb rescue: a new autologous-peripheral blood mononuclear cells technology in critical limb ischemia and chronic ulcers.
    De Angelis B; Gentile P; Orlandi F; Bocchini I; Di Pasquali C; Agovino A; Gizzi C; Patrizi F; Scioli MG; Orlandi A; Cervelli V
    Tissue Eng Part C Methods; 2015 May; 21(5):423-35. PubMed ID: 25341088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia.
    Sun L; Wu L; Qiao Z; Yu J; Li L; Li S; Liu Q; Hu Y; Xu N; Huang P
    Cytotherapy; 2014 Aug; 16(8):1110-6. PubMed ID: 24834816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and Panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia.
    Wang X; Jiang L; Wang X; Yin F; Li G; Feng X; Wang K; Sun S
    Ann Vasc Surg; 2014 Aug; 28(6):1501-12. PubMed ID: 24632316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
    Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
    Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
    Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
    Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.
    Onodera R; Teramukai S; Tanaka S; Kojima S; Horie T; Matoba S; Murohara T; Matsubara H; Fukushima M; ;
    Bone Marrow Transplant; 2011 Feb; 46(2):278-84. PubMed ID: 20479708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary Clinical Efficiency of Autologous Peripheral Blood Mononuclear Cells for Treating Critical Limb Ischemia of Thromboangiitis Obliterans].
    Yu JY; Li SZ; Wu LH; Li HM; Gao WH; Zheng YL; Xu N; Liu QG; Li JF; Liu CH; Hu YM; Huang PP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):892-6. PubMed ID: 27342528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.
    Maione C; Botti C; Coppola CA; Silvestroni C; Lillo S; Schiavone V; Sica G; Sica V; Kumar V; Cobellis G
    Transplant Proc; 2013; 45(1):402-6. PubMed ID: 23375329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
    Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
    Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.
    Ozturk A; Kucukardali Y; Tangi F; Erikci A; Uzun G; Bashekim C; Sen H; Terekeci H; Narin Y; Ozyurt M; Ozkan S; Sayan O; Rodop O; Nalbant S; Sıldıroglu O; Yalnız FF; Senkal IV; Sabuncu H; Oktenli C
    J Diabetes Complications; 2012; 26(1):29-33. PubMed ID: 22240264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of purified CD34+ cells in the treatment of critical limb ischemia.
    Dong Z; Chen B; Fu W; Wang Y; Guo D; Wei Z; Xu X; Mendelsohn FO
    J Vasc Surg; 2013 Aug; 58(2):404-411.e3. PubMed ID: 23611711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma　- Subanalysis of the Long-Term Clinical Outcomes Survey.
    Shoji K; Yanishi K; Yoshimi R; Hamada N; Kondo K; Fujimoto K; Nakajima H; Kuwahara K; Higashi Y; Fukumoto Y; Murohara T; Matoba S;
    Circ J; 2019 Feb; 83(3):662-671. PubMed ID: 30726805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
    Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
    J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.